VIMTALABS638.50

Vimta Labs Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersSUVENTAKEMcap ₹1,416 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q3 FY22
31/12/2021
Q4 FY22
31/03/2022
Q2 FY23
30/09/2022
Q3 FY23
31/12/2022
Q4 FY23
31/03/2023
Q1 FY24
30/06/2023
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Revenue from Operations67.374.179.977.481.883.573.481.779.781.884.789.9
Other Income0.70.40.81.10.70.62.00.90.50.70.71.2
Total Income68.174.580.678.582.584.175.482.680.282.485.491.1
Expenses
+ Cost of Materials Consumed18.217.316.718.818.920.618.319.717.718.718.320.6
+ Changes in Inventories0.00.00.00.00.10.00.00.00.10.00.00.0
+ Employee Benefit Expense19.321.123.323.122.024.725.325.523.724.523.923.4
+ Finance Costs0.20.60.80.70.20.40.60.50.50.50.40.6
+ Depreciation & Amortisation5.66.77.67.88.08.58.98.78.18.28.39.8
+ Other Expenses9.312.714.414.116.713.613.914.613.814.012.612.8
Total Expenses52.658.362.964.465.967.867.169.163.965.963.567.2
EBITDA20.623.025.421.524.224.715.921.824.424.529.933.1
EBIT15.016.417.813.616.116.27.013.116.316.321.623.3
Profit
PBT before Exceptional Items15.516.217.814.116.616.38.413.516.316.521.923.9
Pretax Income15.516.217.814.116.616.38.413.516.316.521.923.9
+ Current Tax4.13.85.54.63.94.73.53.84.94.25.34.5
+ Deferred Tax-0.30.6-0.9-0.8-0.0-0.6-1.5-0.4-0.90.1-0.41.9
Tax Expense3.84.44.53.83.94.12.13.43.94.24.96.4
Net Income11.711.813.210.212.712.26.310.112.412.315.221.5
+ Net Income — Continuing Ops11.711.813.210.212.712.26.310.112.412.317.017.5
+ Net Income — Discontinued Ops0.00.00.00.00.00.00.00.00.00.0-1.84.0
+ Other Comprehensive Income0.0-0.3-0.1-0.10.2-0.0-0.0-0.0-0.2-0.0-0.0-0.0
Total Comprehensive Income11.711.513.110.212.812.26.310.112.112.315.221.5
Per Share
Basic EPS5.285.365.974.625.735.512.854.575.585.546.889.65
Diluted EPS5.175.285.854.515.645.402.834.505.515.476.769.56
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.00.00.00.00.00.00.00.00.00.0-1.84.9
+ Tax — Discontinued Operations0.00.00.00.00.00.00.00.00.00.0-0.10.9
Other Comprehensive Income — detail
+ Items NOT to be Reclassified to P&L-0.10.2-0.0-0.0-0.0-0.3-0.0-0.0-0.0
+ Tax on Items NOT to be Reclassified — alt tag-0.00.1-0.0-0.0-0.0-0.1-0.0-0.0-0.0
Comprehensive Income — Owners of Parent11.70.00.010.20.00.00.010.10.00.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations5.285.365.974.625.735.512.854.575.585.547.687.86
Diluted EPS — Continuing Operations5.175.285.854.515.645.402.834.505.515.477.547.79
Basic EPS — Discontinued Operations0.000.000.000.000.000.000.000.000.000.00-0.801.79
Diluted EPS — Discontinued Operations0.000.000.000.000.000.000.000.000.000.00-0.781.77
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit49.156.863.158.662.962.955.162.062.063.066.469.3
Gross Margin %72.9876.6379.0475.7076.8275.3575.0975.8977.7577.1178.3577.06
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)15.516.217.814.116.616.38.413.516.316.521.923.9
Net Income Adj (tax-effected)11.711.813.210.212.712.26.310.112.412.315.221.5
EPS Adj5.285.365.974.625.735.512.854.575.585.546.889.65
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.002.002.002.002.002.002.00
Paid Up Equity Capital4.44.44.44.44.44.44.44.44.44.44.44.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q3 FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.